UFP Technologies (NASDAQ:UFPT – Get Free Report) and Sensus Healthcare (NASDAQ:SRTS – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability.
Analyst Ratings
This is a summary of recent ratings for UFP Technologies and Sensus Healthcare, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| UFP Technologies | 0 | 2 | 0 | 0 | 2.00 |
| Sensus Healthcare | 1 | 1 | 4 | 0 | 2.50 |
Sensus Healthcare has a consensus price target of $5.83, indicating a potential upside of 107.59%. Given Sensus Healthcare’s stronger consensus rating and higher probable upside, analysts plainly believe Sensus Healthcare is more favorable than UFP Technologies.
Institutional and Insider Ownership
87.3% of UFP Technologies shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 4.6% of UFP Technologies shares are held by insiders. Comparatively, 10.2% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares UFP Technologies and Sensus Healthcare”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| UFP Technologies | $631.64 million | 3.57 | $68.31 million | $9.28 | 31.35 |
| Sensus Healthcare | $27.48 million | 1.68 | -$7.72 million | ($0.94) | -2.99 |
UFP Technologies has higher revenue and earnings than Sensus Healthcare. Sensus Healthcare is trading at a lower price-to-earnings ratio than UFP Technologies, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares UFP Technologies and Sensus Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| UFP Technologies | 11.45% | 18.42% | 11.96% |
| Sensus Healthcare | -88.45% | -21.57% | -19.20% |
Volatility & Risk
UFP Technologies has a beta of 1.04, suggesting that its share price is 4% more volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.18, suggesting that its share price is 18% more volatile than the S&P 500.
Summary
UFP Technologies beats Sensus Healthcare on 9 of the 14 factors compared between the two stocks.
About UFP Technologies
UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.
About Sensus Healthcare
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
